Recovery From Depression Predicts Lower Health Services Costs

Gregory E. Simon, MD, MPH; Rezaul K. Khandker, PhD, MPH; Laura Ichikawa, MS; and Belinda H. Operskalski, MPH

Published: August 15, 2006

Article Abstract

Objective: To examine the association betweenoutcome of acute-phase depression treatment and subsequent healthservices costs.

Method: Data from 9 longitudinal studies ofpatients starting depression treatment were used to examine therelationship between outcome of acute-phase treatment and healthservices costs over the subsequent 6 months. All studies were 2-to 4-year studies conducted between the years 1991 and 2004.Assessment of diagnosis was done using the Inventory ofDepressive Symptoms or the Structured Clinical Interview forDSM-IV. Clinical outcomes were assessed by structured telephoneinterviews using the Hamilton Rating Scale for Depression or a20-item depression scale extracted from the Hopkins SymptomChecklist. Costs were assessed using health plan accountingrecords.

Results: Of 1814 patients entering treatment andmeeting criteria for major depressive episode, 29% had persistentmajor depression 3 to 4 months later, 37% were improved but didnot meet criteria for remission, and 34% achieved remission ofdepression. Those with persistent depression had higher baselinedepression scores and higher health services costs beforebeginning treatment. After adjustment for baseline differences,mean health services costs over the 6 months followingacute-phase treatment were $2012 (95% CI = $1832 to $2210) forthose achieving remission, $2571 (95% CI = $2350 to $2812) forthose improved but not remitted, and $3094 (95% CI = $2802 to$3416) for those with persistent major depression. Average costsfor depression treatment (antidepressant prescriptions,outpatient visits, and mental health inpatient care) ranged from$429 in the full remission group to $585 in the persistentdepression group.

Conclusions: Among patients treated fordepression in community practice, only one third reached fullremission after acute-phase treatment. Compared with persistentdepression, remission is associated with significantly lowersubsequent utilization and costs across the full range of mentalhealth and general medical services.

Volume: 67

Quick Links: Depression (MDD)

Continue Reading…

Subscribe to read the entire article

$40.00

Buy this Article as a PDF

Sign-up to stay
up-to-date today!

SUBSCRIBE

Already registered? Sign In

Original Research

Frontothalamic Circuit Abnormalities in Patients With Bipolar Depression and Suicide Attempts

To identify potential markers for suicide risk, this fMRI study looked at neural activity in bipolar depression...

Read More...